Search

Timothy Patrick Fong

from Davis, CA
Age ~67

Timothy Fong Phones & Addresses

  • 3004 Audubon Cir, Davis, CA 95616 (530) 753-0732
  • Honolulu, HI
  • Oakland, CA
  • Berkeley, CA
  • Monterey Park, CA
  • Yolo, CA

Work

Company: UCLA Neuropsychiatric Hlth Svs Address: 300 Medical Plz Suite 1100, Los Angeles, CA 90095 Phones: (310) 825-9989

Education

School / High School: Northwestern Center Feinberg School of Medicine 1998

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Addiction Psychiatry, 2006

Specialities

Addiction Psychiatry

Professional Records

Medicine Doctors

Timothy Fong Photo 1

Dr. Timothy W Fong, Los Angeles CA - MD (Doctor of Medicine)

View page
Specialties:
Addiction Psychiatry
Address:
UCLA Neuropsychiatric Hlth Svs
300 Medical Plz Suite 1100, Los Angeles, CA 90095
(310) 825-9989 (Phone)
Certifications:
Addiction Psychiatry, 2006
Psychiatry, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Northwestern Center Feinberg School of Medicine
Graduated: 1998
Medical School
UCLA School Of Med
Graduated: 1998
Timothy Fong Photo 2

Timothy W. Fong

View page
Specialties:
Psychiatry, Addiction Medicine
Work:
UCLA Medical GroupUCLA Neuropsychiatric & Behavioral Health Services
300 Medical Plz, Los Angeles, CA 90095
(310) 825-9989 (phone), (310) 267-1908 (fax)
Education:
Medical School
Northwestern University Feinberg School of Medicine
Graduated: 1998
Conditions:
Attention Deficit Disorder (ADD)
Bipolar Disorder
Schizophrenia
Anxiety Dissociative and Somatoform Disorders
Anxiety Phobic Disorders
Languages:
English
Description:
Dr. Fong graduated from the Northwestern University Feinberg School of Medicine in 1998. He works in Los Angeles, CA and specializes in Psychiatry and Addiction Medicine. Dr. Fong is affiliated with Ronald Reagan UCLA Medical Center and Santa Monica UCLA Medical Center.
Timothy Fong Photo 3

Timothy Wayne Fong, Los Angeles CA

View page
Specialties:
Psychiatrist
Address:
760 Westwood Plz, Los Angeles, CA 90024
300 Med Plz, Los Angeles, CA 90095
Board certifications:
American Board of Psychiatry and Neurology Certification in Psychiatry (Psychiatry and Neurology)
American Board of Psychiatry and Neurology Sub-certificate in Addiction Psychiatry (Psychiatry and Neurology)

Lawyers & Attorneys

Timothy Fong Photo 4

Timothy Yett Suen Fong, Santa Clara CA - Lawyer

View page
Address:
Timothy Y. Fong, Attorney at law
3333 Bowers Ave Ste 130, Santa Clara, CA 95054
(408) 627-7810 (Office)
Licenses:
California - Active 2008
Education:
University of San Francisco School of Law
University of California - Berkeley
Specialties:
Litigation - 100%

Resumes

Resumes

Timothy Fong Photo 5

Student At University Of California, Davis

View page
Location:
Sacramento, California Area
Industry:
Hospital & Health Care

Business Records

Name / Title
Company / Classification
Phones & Addresses
Timothy Fong
President
ALLYFORCE, INC
Nonclassifiable Establishments
1808 Octavia St, San Francisco, CA 94109
Timothy Fong
Manager
Fong Gifford Associates
Investment Advices & Business Consulting · Investment Advisory Service Business Consulting Services
3658 Mt Diablo Blvd, Lafayette, CA 94549
(925) 299-7800, (925) 299-7815
Timothy M. Fong
Pastor
Chinese Life Lutheran Church
Higher Education · Religious Organization
433 N Atlantic Blvd, Alhambra, CA 91801
(626) 570-4327, (626) 570-4320
Timothy Wayne Fong
Timothy Fong MD
Psychiatrist
760 Westwood Plz, Los Angeles, CA 90024
(310) 825-0018
Timothy Fong
Managing
Foresight, LLC
Real Estate · Management Services · Nonclassifiable Establishments
3658 Mt Diablo Blvd, Lafayette, CA 94549
Timothy Wayne Fong
Medical Doctor
University of California, Los Angeles
Medical Doctor's Office · College/University
10850 Wilshire Blvd, Los Angeles, CA 90024
760 Westwood Plz, Los Angeles, CA 90024
(310) 206-1233
Timothy Fong
President
LATINO INSTITUTE FOR VIDEO EMPOWERMENT
373 S Cochran Ave #307, Los Angeles, CA 90036

Publications

Us Patents

Cytomodulating Peptides For Treating Interstitial Cystitis

View page
US Patent:
7671026, Mar 2, 2010
Filed:
Nov 17, 2003
Appl. No.:
10/535167
Inventors:
Timothy Fong - Moraga CA, US
Alexis E. Te - Manhasset NY, US
Assignee:
Sangstat Medical Corporation - Fremont CA
International Classification:
A61K 38/08
A61K 38/02
US Classification:
514 15, 514 2
Abstract:
The methods and compositions relate to treatment of disorders of the bladder. In particular, the methods provide for treatment of interstitial cystitis and related disorders. The methods further comprise treatment to affect various manifestations associated with interstitial cystitis, including, reducing histamine release, modulating Substance P expression, modulating nerve growth factor expression, modulating levels of various cytokines, and maintaining integrity of the urine/blood barrier.

Enhancement Of The Immune Response For Vaccine And Gene Therapy Applications

View page
US Patent:
7744900, Jun 29, 2010
Filed:
Apr 29, 2008
Appl. No.:
12/111305
Inventors:
John M Polo - Hayward CA, US
Barbara A Belli - San Diego CA, US
Silvia Perri - Castro Valley CA, US
Timothy C Fong - Moraga CA, US
Assignee:
Novartis Vaccines and Diagnostics, Inc. - Emeryville CA
International Classification:
A61K 39/12
C12P 21/02
C12P 15/00
C07H 21/04
US Classification:
4241991, 4353201, 435 6951, 536 2372
Abstract:
Expression cassettes are provided comprising a promoter operably linked to a nucleic acid molecule which, when transcribed in vivo, forms double-stranded RNA that induces the production of interferon. Expression cassettes also are provided comprising a promoter operably linked to a ribozyme or antisense nucleic acid molecule which, when transcribed in vivo, forms a ribozyme or antisense RNA molecule that stimulates an immune response. In addition, expression cassettes are provided comprising a promoter operably linked to a ribozyme or antisense nucleic acid molecule which, when transcribed in vivo, stimulates apoptosis. Finally, gene delivery vectors are provided which contain such expression cassettes, host cells containing the gene delivery vectors, and methods of utilizing the expression cassettes, gene delivery vectors, and host cells.

Methods Of Expanding Myeloid Cell Populations And Uses Thereof

View page
US Patent:
8252587, Aug 28, 2012
Filed:
Oct 25, 2005
Appl. No.:
11/259592
Inventors:
Timothy C. Fong - Moraga CA, US
Adrianus Geertrudis Wilhelmus Domen - Tuscon AZ, US
Julie Lynne Christensen - Boulder Creek CA, US
Assignee:
Celerant Therapeutics, Inc. - San Carlos CA
International Classification:
C12N 5/078
US Classification:
435372, 435325
Abstract:
The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.

Methods Of Expanding Myeloid Cell Populations And Uses Thereof

View page
US Patent:
8481315, Jul 9, 2013
Filed:
Sep 24, 2012
Appl. No.:
13/625768
Inventors:
Timothy C. Fong - Moraga CA, US
Adrianus Geertrudis Wilhelmus Domen - Tucson AZ, US
Julie Lynne Christensen - Boulder Creek CA, US
Assignee:
Cellerant Therapeutics, Inc. - San Carlos CA
International Classification:
C12N 5/078
US Classification:
435372, 435325
Abstract:
The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.

Abrogen Polypeptides, Nucleic Acids Encoding Them And Methods For Using Them To Inhibit Angiogenesis

View page
US Patent:
20030228298, Dec 11, 2003
Filed:
Sep 4, 2002
Appl. No.:
10/233675
Inventors:
Mark Nesbit - Vincennes, FR
Timothy Fong - Moraga CA, US
Dirk Brockstedt - Oakland CA, US
International Classification:
A61K038/43
C12Q001/68
C07H021/04
C12N009/99
C12P021/02
C12N005/06
US Classification:
424/094100, 435/069200, 435/184000, 435/320100, 435/325000, 536/023200, 435/006000
Abstract:
The invention relates to abrogen polypeptides and nucleic acids that encode them. In general, the abrogen polypeptides comprise the kringle domain from, for example, urokinase plasminogen activator. Abrogen polypeptides can be used to inhibit endothelial cell activation and/or proliferation and can inhibit endothelial cells activated or induced by both bFGF and VEGF. The invention also encompasses methods to produce polypeptides that possess abrogen activity as well as method for using these polypeptides.

Cytomodulating Peptides And Methods For Treating Neurological Disorders

View page
US Patent:
20040186052, Sep 23, 2004
Filed:
Oct 24, 2003
Appl. No.:
10/693331
Inventors:
Suhasini Iyer - San Ramon CA, US
Roland Buelow - Palo Alto CA, US
Mirella Lazarov - Palo Alto CA, US
Timothy Fong - Moraga CA, US
International Classification:
A61K038/17
US Classification:
514/012000
Abstract:
Compositions and methods are provided for inhibiting neuronal cell death and the loss of neuronal contacts resulting from acute and chronic neurological disorders, including neurodegenerative and neuroinflammatory diseases. The subject compositions and methods utilize RDP-58 compositions capable of providing a direct neuroprotective effect on neuronal cells in conjunction with the inhibition of autoimmune and inflammatory processes.

Compositions And Methods For Treating Haematological Proliferative Disorders

View page
US Patent:
20080003224, Jan 3, 2008
Filed:
Jan 29, 2007
Appl. No.:
11/699733
Inventors:
Timothy Fong - Moraga CA, US
Varghese Palath - Fremont CA, US
R. Tesi - Berkeley CA, US
Hoang Tran - Menlo Park CA, US
Irving Weissman - Stanford CA, US
Assignee:
Cellerant Therapeutics, Inc. - San Carlos CA
International Classification:
A61K 39/395
A61K 39/00
A61P 35/00
C07K 16/00
C12N 5/00
C12P 21/08
US Classification:
424139100, 424173100, 435346000, 435375000, 530387100, 530387300
Abstract:
The disclosure relates to antibodies immunoreactive with CD45RA+ hematopoietic tumor cells (HTCs), hybridomas producing such antibodies, and methods of using the antibodies, particularly as therapeutic treatments for conditions or diseases characterized by CD45RA+ HTCs.

Methods Of Expanding Myeloid Cell Populations And Uses Thereof

View page
US Patent:
20130004468, Jan 3, 2013
Filed:
Jul 2, 2012
Appl. No.:
13/540471
Inventors:
Timothy C. Fong - Moraga CA, US
Adrianus Geertrudis Wilhelmus Domen - Tucson AZ, US
Julie Lynne Christensen - Boulder Creek CA, US
Assignee:
Cellerant Therapeutics, Inc. - San Carlos CA
International Classification:
A61K 35/12
C12N 5/0789
US Classification:
424 937, 435325, 435374
Abstract:
The present disclosure relates to a method of expanding myeloid progenitor cells by culturing an initial population of cells in a medium comprising a mixture of cytokines and growth factors that promote growth and expansion of the myeloid progenitor cells. The expanded cell population provides a source of cells as therapeutic treatments for neutropenia and/or thrombocytopenia arising in patients subjected to myeloablative therapy and hematopoietic stem cell transplantation.

Isbn (Books And Publications)

The Contemporary Asian American Experience: Beyond the Model Minority

View page
Author

Timothy P. Fong

ISBN #

0130918342

The Contemporary Asian American Experience: Beyond the Model Minority

View page
Author

Timothy P. Fong

ISBN #

0133627810

Asian Americans: Experiences and Perspectives

View page
Author

Timothy P. Fong

ISBN #

0137429665

Timothy Patrick Fong from Davis, CA, age ~67 Get Report